AMCP's volunteers are vital players in propelling our mission forward. In this installment of the AMCP Volunteer Spotlight, we are featuring Justin Bioc, PharmD.
In June, AMCP hosted the Deep Dive into Prescription Digital Therapeutics Summit, convening expert panelists and attendees from across the industry. Read 10 key takeaway points from the Summit.
This webinar featured a candid conversation with panelists from AMCP’s Market Insights Roundtable on Bridging the Gaps in Precision Oncology: Opportunities in Non-Small Cell Lung Cancer.
Amyotrophic lateral sclerosis (ALS) is a rare, rapidly progressive, and fatal neurodegenerative disease characterized by loss of motor neurons in the brain and spinal cord. On April 27, AMCP convened an expert panel of clinical and managed care stakeholders to increase understanding on how payers can inform strategies to improve the care and treatment of those impacted by ALS.
June 2023 Legislative & Regulatory Briefing: AMCP Advocates Visit Congress for Legislative Days 2023; AMCP Submits Comments on Manufacturer Discount Program Draft Guidance; AMCP to Showcase Prescription Digital Therapeutics (PDTs) on Capitol Hill; AMCP Comments on Proposed Rules Regarding Privacy and Health Data; AMCP, Health Care Organizations Thank the Biden Administration for Relaunching the Cancer Moonshot.